Vivosim Lab Inc (VIVS) Stock Price, Quote & News

Company Profile

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicolo...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 224 1000

Website: vivosim.ai

Address:

11555 Sorrento Valley Road, Suite 100, San Diego, United States

WallStVisions Oct. 3 at 1:59 AM

Watchlist for 10/3/25 🌙🥂 #2 $OPEN $VIVS $UUUU $GORV $IVDA

1 · Reply

MoonCowBoy Oct. 3 at 1:32 AM

$VRPX $VIVS $OM $ITUB _

0 · Reply

1Spartantrade1 Oct. 2 at 6:57 PM

Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize $ANGI $VRPX $VIVS $OM .

0 · Reply

TraderJay85 Oct. 1 at 11:57 PM

PRE-MARKET MOVERS (PMM) $NUAI 1.87 Stop $STFS .2188 $LIMN 1.70 $VIVS 3.27 $GIFI 7.90 Never hold under support. if it goes below then sell. Jump back in if it comes back to last support like YDES. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER ❤️

0 · Reply

SkyeMyers0 Sep. 21 at 3:41 AM

$VIVS Setting up nicely today. Remember: discipline over emotion, process over outcome. Let’s trade smart and finish green. Stay informed about market trends and opportunities! @SkyeMyers0

0 · Reply

_www_larval_com_ Sep. 16 at 3:17 PM

$VIVS just stumbled -10% lower to -14% (~132Kv) a moment ago, 09/19 options, follow for more volatility.

0 · Reply

HeavyDtwitter Sep. 16 at 10:52 AM

$CHEK $IPDN $KAVL $VIVS $FGI FGI400%

0 · Reply

Dameosaurus Sep. 15 at 5:22 PM

$VIVS NXXT executing while many talk gallons growth real contracts sticky demand this is scale with margin tailwinds from tech stack beautiful blend

0 · Reply

SadyK189 Sep. 15 at 2:25 PM

$VIVS My post yesterday "Initially alerted at 2.52. Still looking good on daily chart. Key support at 3.20 - 3.50. Next key level to test is 4.85- 5.20. Currently at 4.20" It hit our desired zone, at 5.15 right now

0 · Reply

dln101 Sep. 15 at 12:58 PM

$CHEK $KAVL $VIVS $IPDN

0 · Reply

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

May 20, 2025, 5:47 AM EDT - 4 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR CLPT EDIT NTLA VANI

May 13, 2025, 8:05 AM EDT - 5 months ago

VivoSim's NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

May 7, 2025, 8:05 AM EDT - 5 months ago

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

Apr 24, 2025, 8:05 AM EDT - 5 months ago

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

Apr 23, 2025, 8:05 AM EDT - 5 months ago

VivoSim to Carry Forward Organovo 3D Bioprinting

Apr 2, 2025, 8:05 AM EDT - 6 months ago

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

Mar 27, 2025, 8:05 AM EDT - 6 months ago

Organovo Provides Business Update

Mar 25, 2025, 11:25 AM EDT - 6 months ago

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

LLY

Mar 19, 2025, 8:05 AM EDT - 7 months ago

Organovo Announces Reverse Stock Split

Mar 11, 2025, 7:00 AM EDT - 7 months ago

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

GRCE MTNB

Mar 6, 2025, 8:05 AM EST - 7 months ago

Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises

Feb 25, 2025, 8:05 AM EST - 7 months ago

Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company

Jan 6, 2025, 8:05 AM EST - 9 months ago

Organovo Announces Appointment of Norman Staskey as Chief Financial Officer

Nov 20, 2024, 8:05 AM EST - 11 months ago

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting

Nov 13, 2024, 8:06 AM EST - 11 months ago

Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases

Jul 18, 2024, 7:55 AM EDT - 1 year ago

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July

ASLN CERO

Jul 16, 2024, 8:05 AM EDT - 1 year ago

Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

May 21, 2024, 8:05 AM EDT - 1 year ago

Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease

May 14, 2024, 11:00 AM EDT - 1 year ago

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

May 8, 2024, 8:00 PM EDT - 1 year ago

Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering

Apr 15, 2024, 8:28 AM EDT - 1 year ago

Organovo's fatty liver disease drug meets main goal in mid-stage study

Apr 15, 2024, 8:05 AM EDT - 1 year ago

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

Jan 25, 2024, 8:05 AM EST - 1 year ago

Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn's and Colitis Congress

Jan 9, 2024, 8:05 AM EST - 1 year ago

Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn's and Colitis Congress

Dec 6, 2023, 8:05 AM EST - 1 year ago

Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results

Nov 13, 2023, 8:05 AM EST - 2 years ago

CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan

Nov 8, 2023, 8:05 AM EST - 2 years ago

Organovo Highlights FXR314 Combination Therapy Potential and Plan

Sep 8, 2023, 12:46 PM EDT - 2 years ago

Organovo to Participate in the H.C. Wainwright Global Investment Conference

Aug 23, 2023, 8:05 AM EDT - 2 years ago

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

Mar 21, 2023, 8:05 AM EDT - 2 years ago

Organovo Announces FXR Program

Nov 15, 2022, 8:05 AM EST - 3 years ago

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn's Disease Drug Candidates

Sep 6, 2022, 8:20 AM EDT - 3 years ago

Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Sep 6, 2022, 8:05 AM EDT - 3 years ago

Organovo Announces Postponement of Annual Meeting of Stockholders

May 17, 2022, 8:05 AM EDT - 3 years ago

Organovo Achieves 3D Tissue Model for Crohn's Disease

Mar 1, 2022, 8:05 AM EST - 3 years ago

UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

Feb 23, 2022, 8:05 AM EST - 3 years ago

Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

Feb 18, 2022, 4:00 PM EST - 3 years ago

Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 18, 2022, 1:00 PM EST - 3 years ago

Organovo Welcomes New Sr. Vice President of Strategy and Business Development

Feb 2, 2022, 12:00 PM EST - 3 years ago

Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents

Jan 10, 2022, 12:00 PM EST - 4 years ago

Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk

Nov 30, 2021, 8:05 AM EST - 4 years ago

Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022

Sep 17, 2021, 4:10 PM EDT - 4 years ago

Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

May 28, 2021, 9:54 AM EDT - 4 years ago

Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside

Mar 11, 2021, 3:58 PM EST - 4 years ago

Catherine Wood's ARK Investment Slashes Organovo Holding

Mar 2, 2021, 8:05 AM EST - 4 years ago

Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)

Sep 3, 2020, 4:05 PM EDT - 5 years ago

Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement

Aug 17, 2020, 8:05 AM EDT - 5 years ago

Organovo Announces One-for-Twenty Reverse Stock Split

Oct 2, 2019, 7:31 PM EDT - 6 years ago

Organovo Acknowledges Receipt of Proposal

May 23, 2019, 5:05 PM EDT - 6 years ago

Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q4 2019 Results - Earnings Call Transcript

WallStVisions Oct. 3 at 1:59 AM

Watchlist for 10/3/25 🌙🥂 #2 $OPEN $VIVS $UUUU $GORV $IVDA

1 · Reply

MoonCowBoy Oct. 3 at 1:32 AM

$VRPX $VIVS $OM $ITUB _

0 · Reply

1Spartantrade1 Oct. 2 at 6:57 PM

0 · Reply

TraderJay85 Oct. 1 at 11:57 PM

0 · Reply

SkyeMyers0 Sep. 21 at 3:41 AM

$VIVS Setting up nicely today. Remember: discipline over emotion, process over outcome. Let’s trade smart and finish green. Stay informed about market trends and opportunities! @SkyeMyers0

0 · Reply

_www_larval_com_ Sep. 16 at 3:17 PM

$VIVS just stumbled -10% lower to -14% (~132Kv) a moment ago, 09/19 options, follow for more volatility.

0 · Reply

HeavyDtwitter Sep. 16 at 10:52 AM

$CHEK $IPDN $KAVL $VIVS $FGI FGI400%

0 · Reply

Dameosaurus Sep. 15 at 5:22 PM

$VIVS NXXT executing while many talk gallons growth real contracts sticky demand this is scale with margin tailwinds from tech stack beautiful blend

0 · Reply

SadyK189 Sep. 15 at 2:25 PM

0 · Reply

dln101 Sep. 15 at 12:58 PM

$CHEK $KAVL $VIVS $IPDN

0 · Reply

BigSqueezeComing Sep. 15 at 9:23 AM

$VIVS daily chart very bullish

0 · Reply

OptixVisual Sep. 15 at 12:09 AM

$MITQ $SXTC $MHUA $VIVS $PBM Good list to take a look at, first being the most with potential.

0 · Reply

kvik Sep. 14 at 11:16 PM

$CIFR $HIVE $VIVS $ENTO $HYPD

0 · Reply

SadyK189 Sep. 14 at 11:06 PM

Stocks that can take time but have good setups on daily chart: $CIFR $HIVE $VIVS $ENTO $HYPD CIFR: Initially alerted at 7.75. Still trending nicely on daily chart. key support at 8.10 - 8.65. Nexy key level to test is 11.90 - 12.65. Overall, it has long term potential of $17+. HIVE: Moving slowly and steadily but nicely on daily chart. Key support at 3 - 3.20. Next key level to test is 4.65 - 4.90. Currently at 3.98. VIVS: Initially alerted at 2.52. Still looking good on daily chart. Key support at 3.20 - 3.50. Next key level to test is 4.85- 5.20. Currently at 4.20. Overall, it has long term potential of 6.7+ ENTO: Good close of daily candle. Key support at 2.40 - 2.65. Next key level to test is 3.75 - 4. Currently at 3.15. HYPD is trending nicely on daily chart. 12.40 - 12.80 is acting as key support zone. Next key level to test is 16.75 - 17.25. Currently at 15.20

0 · Reply

SadyK189 Sep. 12 at 8:15 PM

Here is my Amazing daily Stocktwits report 2 / 2: $BW $KALA $VIVS $IREN $APLD VIVS: My post was "Alerted at 2.52 for break of $3. It's at 3.14. Trending nicely on daily chart. Key support at 2.40 - 2.60. Next key level to test is 3.65 - 3.9" It hit our desired zone, went till 4.28 today KALA: My post was "Looking good on daily chart. Key support at 10.80 - 11.40. Next key level to test is 16.20 - 16.80. Currently at 14.82" It went till 18.88 today BW: My post was "BW is moving slowly and steadily but nicely on daily chart. Key support at 1.75 - 1.90. Next key level to test is 2.80 - 2.95. Currently at 2.47" It went till 2.88 IREN My post was "Looking good on daily chart. Key support at 18 - 19.30. Next key level to test is 31 - 33.50" It hit our desired zone, went till 34.07 APLD My post was "moving nicely on daily chart. 11.30 - 11.70 is acting as key support zone. Next key level to test is 15.75 - 16.10. Currently at 14.70. Overall, it has long term potential of 19+" It went till 18.71

2 · Reply

SadyK189 Sep. 12 at 1:07 AM

Here is my Amazing daily Stocktwits report: $OPEN $AEI $AIRE $VIVS $WHLR OPEN: My post last night "Alerted at 4.41 that its looking good on daily chart. Currently at 8.18. key support zone at 6.10 - 6.55. Next level to test is 9.35 - 9.65" It went till 10.70 AEI: My post last night "Initially alerted at 1.94 for 2.4 - 2.65. Still looking good on daily chart. Key support at 1.8 - 1.95. Next key level to test is 2.7 - 2.9. Currently at 2.33" It made a nice move to 3.77 VIVS: My post last night "Alerted at 2.52 for break of $3. It's at 3.14. Trending nicely on daily chart. Key support at 2.40 - 2.60. Next key level to test is 3.65 - 3.9" It went till 3.73 VNCE: Price 3.86. My post last night "Good close of 4hours candle. Key support at 2.60 - 2.85. Next key level to test is 4.55 - 4.80" It went till 6.13 in pre market. WHLR: My post last night "Getting up on 4hours chart. Key support at 1.95 - 2.15. Next key level to test is 3.45 - 3.70. Currently at 2.79" It went till 3.76 in pre market.

0 · Reply

SadyK189 Sep. 11 at 1:22 AM

Top Stocks to watch tomorrow 2 / 3: $AEI $IMRX $VIVS $VNCE $TGL AEI: Initially alerted at 1.94 for 2.4 - 2.65. It went till 2.43 today. Still looking good on daily chart. Key support at 1.8 - 1.95. Next key level to test is 2.7 - 2.9. Currently at 2.33 IMRX: Initially alerted at 5.75 for 6.55 - 7 zone. Currently at 8.45. Still looking good on daily chart. Key support at 6.40 - 6.80. Next key level to test is 9.15 - 9.50. TGL: Good close of 4hours candle. Key support at 1.35 - 1.50. Next key level to test is 2.45 - 2.65. Currently at 2.02 VIVS: Alerted at 2.52 for break of $3. It's at 3.14. Trending nicely on daily chart. Key support at 2.40 - 2.60. Next key level to test is 3.65 - 3.9. It may take sometime though. VNCE: Good close of 4hours candle. Key support at 2.60 - 2.85. Next key level to test is 4.55 - 4.80. However, it can test key support zone as well. Currently at 3.86.

0 · Reply

Goingupnow1 Sep. 9 at 8:49 PM

$VIVS what’s the story here?

0 · Reply

swingzking Sep. 9 at 7:55 PM

$VIVS Chart primed for fireworks

0 · Reply

BullishAlgo Sep. 6 at 7:13 PM

SKYQ is the ticker that should be on everyone's top list! This will be the next penny to go big! "Sky Quarry Announces Strategic Digital Asset Initiative." -Strategic expansion into digital assets to diversify company's treasury holdings. -Early mover advantage in energy sector's digital assets adoption. -Potential to create a new revenue streams through blockchain integration Make sure you got this and lets bank on it! $TPST $SKBL $ANY $RPID $VIVS

0 · Reply

leopoldstotch Sep. 5 at 7:30 PM

$VIVS Looks like it may flag and bull run on the monthly chart. Will be on my watchlist for Monday. If volume there I may long in the pre market, but looking for a big pop to short. $HOUR $INHD

0 · Reply

Steven1990 Sep. 5 at 6:48 PM

$MLGO $VIVS its running

0 · Reply

Market Cap	9.00M
Revenue (ttm)	140,000.00
Net Income (ttm)	-2.48M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,771.43%
Debt to Equity Ratio	0.00

Volume	71,700
Avg Vol	385,006
Day's Range	N/A - N/A
Shares Out	2.60M
Stochastic %K	50%
Beta	1.13
Analysts	Strong Buy
Price Target	$64.83